Literature DB >> 28745935

Use of Electronic Health Record Data for Quality Reporting.

Amy P Abernethy1, James Gippetti1, Rohit Parulkar1, Cindy Revol1.   

Abstract

Mesh：

Year:  2017        PMID： 28745935     DOI： 10.1200/JOP.2017.024224

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  16 in total

1.  Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer.

Authors:  Emily Feld; Joanna Harton; Neal J Meropol; Blythe J S Adamson; Aaron Cohen; Ravi B Parikh; Matthew D Galsky; Vivek Narayan; John Christodouleas; David J Vaughn; Rebecca A Hubbard; Ronac Mamtani
Journal:  Eur Urol       Date:  2019-07-28       Impact factor: 20.096

2.  Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid Cancers.

Authors:  Ravi B Parikh; Eun Jeong Min; E Paul Wileyto; Fauzia Riaz; Cary P Gross; Roger B Cohen; Rebecca A Hubbard; Qi Long; Ronac Mamtani
Journal:  JAMA Oncol       Date:  2021-12-01       Impact factor: 31.777

3.  Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period.

Authors:  Amy J Davidoff; Scott F Huntington; Natalia Neparidze; Rong Wang; Amer M Zeidan; Nikolai A Podoltsev; Rory M Shallis; Xiaomei Ma
Journal:  Leukemia       Date:  2022-06-27       Impact factor: 12.883

4.  Incidence of Elevated Aminotransferases With or Without Bilirubin Elevation During Treatment With Immune Checkpoint Inhibitors: A Retrospective Study of Patients From Community Oncology Clinics in the United States.

Authors:  Christopher Kim; Shao Zhu; Hosein Kouros-Mehr; Sophia Khaldoyanidi
Journal:  Cureus       Date:  2022-04-11

5.  Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.

Authors:  Anish Thomas; Idrees Mian; Camille Tlemsani; Lorinc Pongor; Nobuyuki Takahashi; Kathleen Maignan; Jeremy Snider; Gerald Li; Garrett Frampton; Siraj Ali; Sehyun Kim; Samantha Nichols; Vinodh Rajapakse; Udayan Guha; Elad Sharon; Junya Fujimoto; Cesar A Moran; Ignacio I Wistuba; Jun S Wei; Javed Khan; Eva Szabo; Aracelis Z Torres; Kenneth R Carson
Journal:  Chest       Date:  2020-05-26       Impact factor: 9.410

Review 6.  Moving beyond static survivorship care plans: A systems engineering approach to population health management for cancer survivors.

Authors:  Amye J Tevaarwerk; Jennifer R Klemp; Gijsberta J van Londen; Bradford W Hesse; Mary E Sesto
Journal:  Cancer       Date:  2018-09-12       Impact factor: 6.860

7.  Bias Reduction Methods for Propensity Scores Estimated from Error-Prone EHR-Derived Covariates.

Authors:  Joanna Harton; Ronac Mamtani; Nandita Mitra; Rebecca A Hubbard
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-09-10

8.  Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer.

Authors:  Martin G Seneviratne; Tina Seto; Douglas W Blayney; James D Brooks; Tina Hernandez-Boussard
Journal:  EGEMS (Wash DC)       Date:  2018-06-01

9.  Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab.

Authors:  Christopher Nevala-Plagemann; Justin Moser; Glynn Weldon Gilcrease; Ignacio Garrido-Laguna
Journal:  ESMO Open       Date:  2019-07-31

10.  Significant Gains in Rheumatoid Arthritis Quality Measures Among RISE Registry Practices.

Authors:  Zara Izadi; Gabriela Schmajuk; Milena Gianfrancesco; Meera Subash; Michael Evans; Laura Trupin; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-12-27       Impact factor: 4.794
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.